HSE issues warning over sunbed use as skin cancer diagnoses rise above 11,000
The HSE has said there are 'lessons to be learnt' from Australia, where a ban on commercial sunbeds has been in place since 2016.
Skin cancer is the most common form of cancer in Ireland, with more than 11,000 cases diagnosed every year.
An event is being held by the HSE's National Cancer Control Programme (NCCP) and the Institute of Public Health (IPH) to discuss sunbed use in Ireland and explore future options for reducing skin cancer in Ireland
"Skin cancer is a significant public health problem in Ireland,' public health specialist for the NCCP Dr Breeda Neville said.
"The majority of skin cancers are caused by UV exposure, which means that skin cancer is largely preventable by protecting your skin from the sun's UV rays and by not using sunbeds.'
Skin cancer diagnoses include cases of both melanoma and non-melanoma skin cancer.
Selling or hiring a sunbed to anyone under 18 is already illegal in Ireland, while a mandate to 'explore ways to ban commercial sunbed use' is included in the Programme for Government.
The HSE has said using a sunbed is 'never safe' and exposing the skin to UV radiation from the sun or sunbeds damages skin cells, accelerates visible signs of ageing and increases the risk of developing skin cancer.
'There is a precedent for the successful banning of sunbeds. Australia introduced an outright ban on commercial sunbeds in 2016,' Craig Sinclair of the World Health Organisation (WHO) said at the event.
"The measure has enjoyed strong public support and has undoubtedly prevented thousands of skin cancers and delivered an estimated saving of over AU$64 million to the Australian Health system.'
The use of UV-emitting devices like sunbeds is classified as carcinogenic to humans by the International Agency for Research on Cancer (IARC). An IARC study has found using a sunbed for the first time before the age of 35 can increase the risk of developing melanoma skin cancer by 75pc.
'We have recently undertaken a comprehensive assessment of sunbed use in Ireland,' Minister of State for Public Health Jennifer Murnane O'Connor said.
"The findings will inform the National Skin Cancer Prevention Plan and provide policy options to reduce skin cancer risk. The Institute of Public Health looks forward to publishing our report in the coming weeks.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
RTÉ News
4 hours ago
- RTÉ News
Payments from drug firms to health professionals widespread, review finds
A new review has found that the practice of drug company payments to healthcare professionals and health organisations in Ireland is widespread. It recommends that the Health Service Executive should highlight that it does not support pharmaceutical industry payments to HSE healthcare professionals, accepting that such payments may influence behaviour in a negative way in terms of prescribing medicines. Data analysis for 2023 for the study shows that drug companies in Ireland made 4,509 payments to healthcare professionals and healthcare organisations, amounting to over €14.4m that year. The highest individual payment during the year by a drug company was €50,462 to a medical practitioner. There were 3,508 payments to healthcare professionals, amounting to €5.5m and 64 payments that exceeded €8,000. The review was conducted by Professor Michael Barry, Clinical Director of the National Centre for Pharmacoeconomics, which conducts assessments on the cost effectiveness of medicines for the HSE to consider, when making decisions on whether medicines should be made available for the public system. Prof Barry has advised the HSE that it should demand a 100% disclosure rate for all healthcare professionals and healthcare organisations in receipt of payments from the pharmaceutical industry. In his review of the 2023 payments, Prof Barry says that drug companies fund many healthcare settings, like hospitals and universities, where education and professional development take place. The industry also funds some medical societies. Prof Barry said the concern is not only are some societies involved in the education, research and development of prescribers, but some may also be involved in generating treatment guidelines. The payments by companies are publicly disclosed in accordance with the Irish Pharmaceutical Healthcare Association (IPHA) code of practice since 2016. The details on the public website come from up to 50 companies, including non-IPHA members. The payments, officially called Transfer of Value, are made for research and development, donations and sponsorship (including medical education), consultancy fees, registration fees for health staff and travel costs to attend events. The company that made the greatest number of payments to healthcare professionals was Novartis, with 374 such payments. Abbvie paid the most to healthcare professionals, amounting to €880,952. Prof Barry said that many would consider that the pharmaceutical industry should not have any role in the education of healthcare professionals and prescribers. He said that the medical literature has highlighted that doctors with ties to industry may be more inclined than their colleagues to prescribe a brand name drug, despite the availability of a cheaper generic version. Pharmaceutical industry 'committed to integrity and transparency' The Irish Pharmaceutical Healthcare Association (IPHA) said that under the latest data for 2024, a record level of 98% of healthcare professionals had provided named transparency on the payments received. It said that since 2016, companies have disclosed the financial payments, whether direct, or indirect, in cash or in kind, made to healthcare professionals and healthcare organisations. It also said that the latest data for 2024, just published, shows that payments to healthcare professionals came to €5.6m, a 4% decrease on the 2023 figure. It added that €178,169 was paid to 74 unnamed healthcare professionals last year, according to the data. The IPHA said the total amount paid to healthcare organisations last year was also down 3%, at over €8.6m, compared to the previous year. All healthcare organisations in receipt of the payments were disclosed individually last year, which the association said meant 100% transparency. The IPHA said that while its members are required to disclose the payments, currently, of the 51 companies who publish their data through the platform, 11 are non-IPHA members and 40 are IPHA members. The association said it is committed to integrity and transparency in all these interactions and the aim is to reach 100% named disclosure for healthcare professionals and it will support member companies in using legitimate interest, as a legal basis for making these disclosures under data protection law.
Irish Examiner
10 hours ago
- Irish Examiner
Preventing avoidable baby deaths means having all the information
Ask the HSE what the main risk factors for stillbirths are and it will tell you, but ask how many avoidable baby deaths there have been in maternity units since 2013 and it won't. It does know, but it just won't tell you. While the HSE will accept that 'all elements of healthcare have adverse events', it will always insist every effort is made to learn from these events and reduce the risk of recurrence. But 'every effort' so far does not extend to acceding to calls by maternity reform advocates to publicly announce a review of 50-plus baby death inquests since 2013. The HSE's determination to learn from these tragedies also does not extend to publicly acknowledging any attempt to find out what were the outcomes of all 655 baby deaths and injuries classed as Serious Reportable Events reported to the HSE's National Incident Management System between 2016 and 2023. No matter how many times the HSE or the Department of Health are asked, they insist there is little or no point in reviewing either of these sources of information. Last spring, this reporter was informed by a senior HSE executive that 'we know about all of these deaths' — so perhaps they feel they have all the answers. But if that is the case, why are babies still dying avoidable deaths in Ireland? Perhaps the answer lies in a growing view among women that they are being gaslighted into believing they are among the main reasons for their babies' deaths. On the list of risk factors for stillbirths, for example, the HSE says there are congenital anomalies (birth defects) in babies and things like the age, BMI, and the socioeconomic background of mothers. It will say risk factors centre around lifestyle choices such as drinking, smoking, and taking drugs. But what gets little attention in the panoply of health service information is the elephant in the room of Irish health services, and in particular maternity services; human error. Hardly a few months go by and another anguished mother is sobbing at the steps of either a coroner's court or the High Court as she recounts how what happened to her baby shouldn't have happened. Like so many others since 2013, Lisa Duffy received an apology from the HSE for care failings. She was promised that lessons would be learned. The apology came at her son Luke's inquest in January 2022, which resulted in a verdict of medical misadventure. Luke was stillborn in 2018 at Portlaoise Hospital, after — among other things — midwives failed to spot that Lisa was in labour. Since experiencing Baby Luke's 'needless loss', she has been at the forefront of maternity reform advocacy. Mel and Lisa Duffy holding a framed photo of Baby Luke after he was stillborn. Since experiencing Baby Luke's 'needless loss', Lisa has been at the forefront of maternity reform advocacy. 'You don't realise the extent to which things can go wrong despite you and your baby being perfectly fit and healthy,' she recalls. 'You also just take it for granted that you will be cared for and trained staff will do their jobs properly. 'But bitter experience has shown me and so many other mums and dads that you can take nothing for granted. They will tell you there are lifestyle factors and there are these congenital anomalies but what they won't talk about in any great detail are the mistakes that get made. Women are gaslighted into believing the main reasons are themselves or their babies. 'Yet, as I and so many others have discovered, human error is also a big cause not just of avoidable baby deaths but also birth injuries.' It was Lisa's help with Irish Examiner-initiated research in 2023 that led to the discovery that there have been at least 56 avoidable baby deaths in maternity units in less than a decade. Cardiotocography (CTG) monitoring The research, based on a review of reports of inquests into babies who died between 2013 and 2022, led to calls for a review of avoidable baby death. The research threw up a number of factors common to cases, such as delayed deliveries, a lack of appropriate training and communications failures by staff. The biggest single factor in 28 of the 56 deaths was related to cardiotocography (CTG) monitoring of babies' hearts and the mothers' contractions. On December 21, 2023, the then health minister denied in an RTÉ interview that there was any 'trend' in relation to CTG playing a factor in baby deaths. Stephen Donnelly's response came weeks after the State Claims Agency itself stated, in a review of 'Catastrophic Claims relating to Babies in Maternity Services', that issues around CTG had indeed played a major factor in claims. In its review of 80 catastrophic claims concluded between 2015 and 2019, it noted health staff 'failed to interpret or recognise' abnormal CTG trace results in more than 60% of claims over the five-year period. Rise in baby deaths Research, again by the Irish Examiner, has discovered there have been five times more baby deaths and baby birth-related injuries reported to the HSE in 2023 compared to 2016. The figures, released under Freedom of Information legislation, relate solely to near-term and term babies weighing more than 2,500g or 5.5lbs. In total, there were 655 Serious Reportable Events (SREs) involving babies reported to the HSE between 2016 and 2023. But the agency can't say how many of the 655 baby deaths and birth injuries reported to its National Incident Management System resulted in a negative outcome. This is because they don't collate the information centrally. Instead they say each hospital is left with primary responsibility — 'and accountability' — for the effective management of incidents. Indeed, if you ask them why they can't just ask each hospital what the outcomes were, the HSE will insist that it is not as simple as 'sending around a few emails'. Instead of going back over the SRE reports, the HSE instead launched a new initiative that will take years to complete. This is the confidential inquiry the National Women and Infants Health Programme (NWIHP) launched last year into data about still and newborn baby deaths between 2021 and 2023. Cases to be examined have been identified from existing perinatal death audit data from the National Perinatal Epidemiology Centre (NPEC), based in Cork. When asked why a new process was started instead of studying the outcomes of 655 baby deaths and baby injury related SREs, the message was the same; it's just not that simple. England has a huge problem with preventable deaths, with a parliamentary report in 2021 openly acknowledging thousands of babies die preventable deaths in NHS maternity units every year. Is it not time for the Irish health service to do the same? Or is it just not that simple?
Irish Independent
18 hours ago
- Irish Independent
Revealed: Parts of the country at risk of becoming GP blackspots
The analysis for the Department of Health said there may be no family doctors to take up practice when current GPs retire in these areas. It highlights the pressure on GP surgeries particularly in areas where the population has increased and aged including Cavan, Meath, Kildare, Louth, Westmeath and Wicklow. There were 3,262 clinically active GPs in 2022. The practice most at risk of not having a replacement GP are mostly single-handed surgeries with one doctor. These are mostly found in Mayo, west Donegal, Limerick, Tipperary, Wexford, Leitrim and Galway. The report calls for better succession planning and more incentives for GPs in areas under most pressure. It said that capacity constraints can be managed by 2030 through a greater flow of doctors coming from training. At that point 4,000 graduates and doctors recruited from abroad are due to come on stream as over 1,000 doctors are set to retire. 'Intake to the GP training scheme has increased by 86pc since 2015. Accounting for attrition of graduates and the possibly higher productivity of older GPs, by 2030 around 2.2 GP national graduates will have on-boarded relative to each GP who becomes inactive.' Inadequate succession planning for retirement may be a risk to the stable supply of GP services in some areas, with single GP practices making up half of the risk group. ADVERTISEMENT Learn more However, the HSE appears to be effective in identifying and supporting panels at risk. Still, there remain a few locations where vacancies persist – these arise equally between rural areas and non-city urban areas, it said. There is some indication that GPs could be deferring retirement in capacity-constrained areas, said the report. Young GMS contract-holders often set up in areas that neighbour those with capacity constraints. As such, access to a GP may be feasible in many areas that are identified as having low capacity, but may indicate that people living near the boundaries of the geographic areas travel into neighbouring areas for care, it pointed out. Just over one in five GPs are in single-GP practices and a further one in five GPs operate from two-person practices. In areas where single GP practices are common but the population is ageing, general practice nurses and midwives (GPNM) numbers are relatively high, which may be offsetting high service usage. There are strong health service management, health outcome and economic rationales for general practices structured around group practices. Coverage of major schemes such as the modernisation scheme and the under 6 contract is high. However, uptake of contracts related to the maternity and infant scheme, childhood immunisation, and cancer screening are low in these areas suggesting that continuity of supply in terms of GP workforce may affect access to healthcare. Meath and central Cork have relatively low uptake of the GMS contract despite being areas with relatively higher cardholding populations There are areas where average panel size remains high regardless of assumed contract-sharing: in North Donegal, East Mayo, and South Wexford, there are a high amount of public patients and relatively low number of GPs.
